Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ADT

Crystal structure of human tankyrase 2 in complex with OD73

Summary for 5ADT
Entry DOI10.2210/pdb5adt/pdb
Related5ADQ 5ADR 5ADS
DescriptorTANKYRASE-2, BICARBONATE ION, SULFATE ION, ... (7 entities in total)
Functional Keywordstransferase, protein-ligand complex, diphtheria toxin like fold, adp- ribosylation, transferase-transferase inhibitor complex
Biological sourceHOMO SAPIENS (HUMAN)
More
Cellular locationCytoplasm: Q9H2K2 Q9H2K2
Total number of polymer chains2
Total formula weight27991.08
Authors
Haikarainen, T.,Lehtio, L. (deposition date: 2015-08-24, release date: 2016-01-13, Last modification date: 2024-05-08)
Primary citationHaikarainen, T.,Waaler, J.,Ignatev, A.,Nkizinkiko, Y.,Venkannagari, H.,Obaji, E.,Krauss, S.,Lehtio, L.
Development and Structural Analysis of Adenosine Site Binding Tankyrase Inhibitors.
Bioorg.Med.Chem.Lett., 26:328-, 2016
Cited by
PubMed Abstract: Tankyrases 1 and 2, the specialized members of the ARTD protein family, are druggable biotargets whose inhibition may have therapeutic potential against cancer, metabolic disease, fibrotic disease, fibrotic wound healing and HSV viral infections. We have previously identified a novel tankyrase inhibitor scaffold, JW55, and showed that it reduces mouse colon adenoma formation in vivo. Here we expanded the scaffold and profiled the selectivity of the compounds against a panel of human ARTDs. The scaffold also enables a fine modulation of selectivity towards either tankyrase 1 or tankyrase 2. In order to get insight about the binding mode of the inhibitors, we solved crystal structures of the compounds in complex with tankyrase 2. The compounds bind to the adenosine pocket of the catalytic domain and cause changes in the protein structure that are modulated by the chemical modifications of the compounds. The structural analysis allows further rational development of this compound class as a potent and selective tankyrase inhibitor.
PubMed: 26706174
DOI: 10.1016/J.BMCL.2015.12.018
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.15 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon